Elanco Animal Well being (NYSE:ELAN – Get Score) up to date its FY 2022 earnings steerage on Friday. The corporate supplied earnings per share steerage of $1.01-$1.07 for the interval, in comparison with the consensus earnings per share estimate of $1.05. The corporate issued income steerage of $4.38 billion-$4.43 billion, in comparison with the consensus income estimate of $4.41 billion.
Analyst Upgrades and Downgrades
→ The Subsequent Large Disaster Is Right here (From Porter & Firm)
A lot of brokerages just lately weighed in on ELAN. The Goldman Sachs Group decreased their worth goal on Elanco Animal Well being from $19.00 to $12.00 and set a promote ranking on the inventory in a analysis report on Wednesday, November ninth. TheStreet downgraded Elanco Animal Well being from a c- ranking to a d+ ranking in a report on Tuesday, October 4th. JPMorgan Chase & Co. decreased their worth goal on Elanco Animal Well being from $24.00 to $20.00 and set a impartial ranking for the corporate in a analysis word on Monday, October seventeenth. Piper Sandler decreased their goal worth on shares of Elanco Animal Well being from $21.00 to $15.00 and set a impartial ranking for the corporate in a analysis report on Monday, November 14th. Lastly, William Blair restated a market carry out ranking on shares of Elanco Animal Well being in a analysis report on Tuesday, November eighth. One analyst has rated the inventory with a promote ranking and 6 have assigned a maintain ranking to the corporate’s inventory. In keeping with information from MarketBeat, Elanco Animal Well being has a median ranking of Maintain and a consensus worth goal of $17.83.
Elanco Animal Well being Value Efficiency
ELAN inventory opened at $13.88 on Friday. The inventory’s 50 day easy shifting common is $12.55 and its 200 day easy shifting common is $14.49. The corporate has a fast ratio of 1.12, a present ratio of 1.96 and a debt-to-equity ratio of 0.82. Elanco Animal Well being has a fifty-two week low of $11.18 and a fifty-two week excessive of $29.66.
Elanco Animal Well being (NYSE:ELAN – Get Score) final issued its earnings outcomes on Tuesday, November eighth. The corporate reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The corporate had income of $1.03 billion for the quarter, in comparison with analyst estimates of $1.03 billion. Elanco Animal Well being had a optimistic return on fairness of seven.65% and a unfavorable internet margin of two.64%. Equities analysis analysts forecast that Elanco Animal Well being will publish 1.04 EPS for the present fiscal 12 months.
Insider Transactions at Elanco Animal Well being
In associated information, Director John P. Bilbrey acquired 7,500 shares of the inventory in a transaction dated Friday, November eleventh. The inventory was bought at a median value of $13.24 per share, with a complete worth of $99,300.00. Following the completion of the acquisition, the director now straight owns 41,722 shares within the firm, valued at roughly $552,399.28. The acquisition was disclosed in a submitting with the SEC, which is offered via this hyperlink. 6.40% of the inventory is at the moment owned by insiders.
Hedge Funds Weigh In On Elanco Animal Well being
A lot of hedge funds have just lately purchased and offered shares of the corporate. KB Monetary Companions LLC elevated its place in shares of Elanco Animal Well being by 8.2% through the first quarter. KB Monetary Companions LLC now owns 8,709 shares of the corporate’s inventory valued at $227,000 after buying a further 658 shares over the last quarter. Baird Monetary Group Inc. elevated its place in shares of Elanco Animal Well being by 1.8% through the third quarter. Baird Monetary Group Inc. now owns 47,406 shares of the corporate’s inventory valued at $589,000 after buying a further 843 shares over the last quarter. Captrust Monetary Advisors raised its stake in shares of Elanco Animal Well being by 57.0% through the 1st quarter. Captrust Monetary Advisors now owns 2,690 shares of the corporate’s inventory price $70,000 after buying a further 977 shares through the interval. Neuberger Berman Group LLC raised its stake in shares of Elanco Animal Well being by 14.9% through the 1st quarter. Neuberger Berman Group LLC now owns 11,071 shares of the corporate’s inventory price $289,000 after buying a further 1,432 shares through the interval. Lastly, Guggenheim Capital LLC boosted its holdings in shares of Elanco Animal Well being by 12.5% within the third quarter. Guggenheim Capital LLC now owns 13,510 shares of the corporate’s inventory price $168,000 after shopping for a further 1,506 shares over the last quarter.
Elanco Animal Well being Firm Profile
Elanco Animal Well being Integrated, an animal well being firm, innovates, develops, manufactures, and markets merchandise for pets and cattle. It affords pet well being illness prevention merchandise, equivalent to parasiticide and vaccine merchandise that shield pets from worms, fleas, and ticks underneath the Seresto, Benefit, Advantix, and Advocate manufacturers; pet well being therapeutics for ache, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines underneath the Galliprant and Claro manufacturers; vaccines, antibiotics, parasiticides, and different merchandise to be used in poultry and aquaculture manufacturing, in addition to dietary well being merchandise, together with enzymes, probiotics, and prebiotics; and a variety of vaccines, antibiotics, implants, parasiticides, and different merchandise utilized in ruminant and swine manufacturing underneath the Rumensin and Baytril manufacturers.
Featured Tales
This on the spot information alert was generated by narrative science expertise and monetary information from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial group previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you contemplate Elanco Animal Well being, you may wish to hear this.
MarketBeat retains monitor of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they advocate to their shoppers each day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Elanco Animal Well being wasn’t on the listing.
Whereas Elanco Animal Well being at the moment has a “Maintain” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
from NYSE Updates – My Blog https://ift.tt/mH4RUNz
via IFTTT
No comments:
Post a Comment